Progentec Diagnostics

GLX Analytix

This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.

Scipher Medicine

This company develops blood tests that use artificial intelligence to match autoimmune disease patients with effective therapies for clinicians and pharmaceutical partners.

Aptatek Biosciences

This company develops portable diagnostic devices for home monitoring of biomarkers to help patients manage chronic conditions such as phenylketonuria.

Prometheus Biosciences

This biotechnology company develops precision medicine therapies and companion diagnostic tests for patients with inflammatory bowel disease and other immune-mediated conditions.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

Resolve Therapeutics

This biopharmaceutical company develops non-immunosuppressive biologics for patients with autoimmune diseases, including lupus and Sjögren's syndrome.

Kyverna Therapeutics

This biopharmaceutical company develops chimeric antigen receptor T-cell therapies for patients with B-cell driven autoimmune diseases such as multiple sclerosis and lupus nephritis.

Presymptom Health

This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.